Dose-dependent effect of intracerebroventricular injection of ouabain on the phosphorylation of the MEK1/2-ERK1/2-p90RSK pathway in the rat brain related to locomotor activity

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 7, 2008, Pages 1637-1642

  Kim, Se Hyun ^a,b   Yu, Hyun Sook ^b   Park, Hong Geun ^b   Jeon, Won Je ^b   Song, Joo Yun ^a   Kang, Ung Gu ^a   Ahn, Yong Min ^a   Lee, Young Han ^c   Kim, Yong Sik ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Konkuk University   (South Korea)

Author keywords

Bipolar disorder; Mitogen activated protein kinase; Na K ATPase

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; OUABAIN; S6 KINASE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG DOSE COMPARISON; ENZYME PHOSPHORYLATION; FRONTAL CORTEX; HIPPOCAMPUS; IMMUNOBLOTTING; IMMUNOREACTIVITY; LOCOMOTION; MALE; NONHUMAN; RAT; STATISTICAL ANALYSIS;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INJECTIONS, INTRAVENTRICULAR; MALE; MOTOR ACTIVITY; OUABAIN; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 51349128054     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2008.05.027     Document Type: Article

References (41)

1. Abramowitz J., Dai C., Hirschi K.K., Dmitrieva R.I., Doris P.A., Liu L., et al. Ouabain- and marinobufagenin-induced proliferation of human umbilical vein smooth muscle cells and a rat vascular smooth muscle cell line, A7r5. Circulation 108 (2003) 3048-3053
2. Ahn Y.M., Seo M.S., Kim S.H., Kim Y., Yoon S.C., Juhnn Y.S., et al. Increased phosphorylation of Ser473-Akt, Ser9-GSK-3beta and Ser133-CREB in the rat frontal cortex after MK-801 intraperitoneal injection. Int J Neuropsychopharmacol 8 (2005) 607-613
3. Ahn Y.M., Seo M.S., Kim S.H., Kim Y., Juhnn Y.S., and Kim Y.S. The effects of MK-801 on the phosphorylation of Ser338-c-Raf-MEK-ERK pathway in the rat frontal cortex. Int J Neuropsychopharmacol 9 (2006) 451-456
4. Aperia A. New roles for an old enzyme: Na,K-ATPase emerges as an interesting drug target. J Intern Med 261 (2007) 44-52
5. Chen G., and Manji H.K. The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers. Curr Opin Psychiatry 19 (2006) 313-323
6. Choe E.S., Chung K.T., Mao L., and Wang J.Q. Amphetamine increases phosphorylation of extracellular signal-regulated kinase and transcription factors in the rat striatum via group I metabotropic glutamate receptors. Neuropsychopharmacology 27 (2002) 565-575
7. Christo P.J., and El-Mallakh R.S. Possible role of endogenous ouabain-like compounds in the pathophysiology of bipolar illness. Med Hypotheses 41 (1993) 378-383
8. Chueh S.C., Guh J.H., Chen J., Lai M.K., and Teng C.M. Dual effects of ouabain on the regulation of proliferation and apoptosis in human prostatic smooth muscle cells. J Urol 166 (2001) 347-353
9. Duman C.H., Schlesinger L., Kodama M., Russell D.S., and Duman R.S. A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Biol Psychiatry 61 (2007) 661-670
10. Einat H., Yuan P., Gould T.D., Li J., Du J., Zhang L., et al. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J Neurosci 23 (2003) 7311-7316
11. El-Mallakh R.S., Hedges S., and Casey D. Digoxin encephalopathy presenting as mood disturbance. J Clin Psychopharmacol 15 (1995) 82-83
12. El-Mallakh R.S., Harrison L.T., Li R., Changaris D.G., and Levy R.S. An animal model for mania: preliminary results. Prog Neuropsychopharmacol Biol Psychiatry 19 (1995) 955-962
13. El-Mallakh R.S., El-Masri M.A., Huff M.O., Li X.P., Decker S., and Levy R.S. Intracerebroventricular administration of ouabain as a model of mania in rats. Bipolar Disord 5 (2003) 362-365
14. El-Mallakh R.S., Decker S., Morris M., Li X.P., Huff M.O., El-Masri M.A., et al. Efficacy of olanzapine and haloperidol in an animal model of mania. Prog Neuropsychopharmacol Biol Psychiatry 30 (2006) 1261-1264
15. Fedorova O.V., Talan M.I., Agalakova N.I., Lakatta E.G., and Bagrov A.Y. Endogenous ligand of alpha(1) sodium pump, marinobufagenin, is a novel mediator of sodium chloride-dependent hypertension. Circulation 105 (2002) 1122-1127
16. Goldstein I., Levy T., Galili D., Ovadia H., Yirmiya R., Rosen H., et al. Involvement of Na(+), K(+)-ATPase and endogenous digitalis-like compounds in depressive disorders. Biol Psychiatry 60 (2006) 491-499
17. Grider G., El-Mallakh R.S., Huff M.O., Buss T.J., Miller J., and Valdes Jr. R. Endogenous digoxin-like immunoreactive factor (DLIF) serum concentrations are decreased in manic bipolar patients compared to normal controls. J Affect Disord 54 (1999) 261-267
18. Haas M., Askari A., and Xie Z. Involvement of Src and epidermal growth factor receptor in the signal-transducing function of Na+/K+-ATPase. J Biol Chem 275 (2000) 27832-27837
19. Hamlyn J.M., Blaustein M.P., Bova S., DuCharme D.W., Harris D.W., Mandel F., et al. Identification and characterization of an ouabain-like compound from human plasma. Proc Natl Acad Sci U S A 88 (1991) 6259-6263
20. Herman L., Hougland T., and El-Mallakh R.S. Mimicking human bipolar ion dysregulation models mania in rats. Neurosci Biobehav Rev 31 (2007) 874-881
21. Li R., El-Mallakh R.S., Harrison L., Changaris D.G., and Levy R.S. Lithium prevents ouabain-induced behavioral changes. Toward an animal model for manic depression. Mol Chem Neuropathol 31 (1997) 65-72
22. Lichtstein D., Samuelov S., and Bourrit A. Characterization of the stimulation of neuronal Na, K-ATPase activity by low concentrations of ouabain. Neurochem Int 7 (1985) 709-715
23. Lichtstein D., Gati I., Samuelov S., Berson D., Rozenman Y., Landau L., et al. Identification of digitalis-like compounds in human cataractous lenses. Eur J Biochem 216 (1993) 261-268
24. Looney S.W., and El-Mallakh R.S. Meta-analysis of erythrocyte Na,K-ATPase activity in bipolar illness. Depress Anxiety 5 (1997) 53-65
25. McCarren M., and Alger B.E. Sodium-potassium pump inhibitors increase neuronal excitability in the rat hippocampal slice: role of a Ca2+-dependant conductance. J Neurophysiol 57 (1989) 496-509
26. Miyakawa-Naito A., Uhlen P., Lal M., Aizman O., Mikoshiba K., Brismar H., et al. Cell signaling microdomain with Na,K-ATPase and inositol 1,4,5-trisphosphate receptor generates calcium oscillations. J Biol Chem 278 (2003) 50355-50361
27. Moseley A.E., Williams M.T., Schaefer T.L., Bohanan C.S., Neumann J.C., Behbehani M.M., et al. Deficiency in Na,K-ATPase alpha isoform genes alters spatial learning, motor activity, and anxiety in mice. J Neurosci 27 (2007) 616-626
28. Mynett-Johnson L., Murphy V., McCormack J., Shields D.C., Claffey E., Manley P., et al. Evidence for an allelic association between bipolar disorder and a Na+, K+ adenosine triphosphatase alpha subunit gene (ATP1A3). Biol Psychiatry 44 (1998) 47-51
29. Nesher M., Shpolansky U., Rosen H., and Lichtstein D. The digitalis-like steroid hormones: new mechanisms of action and biological significance. Life Sci 80 (2007) 2093-2107
30. Paxinos G., and Watson C. The rat brain in stereotactic coordinates. 4th ed. (1998), Academic Press, Sydney
31. Ramirez-Ortega M., Maldonado-Lagunas V., Melendez-Zajgla J., Carrillo-Hernandez J.F., Pastelin-Hernandez G., Picazo-Picazo O., et al. Proliferation and apoptosis of HeLa cells induced by in vitro stimulation with digitalis. Eur J Pharmacol 534 (2006) 71-76
32. Rose A.M., Mellett B.J., Valdes Jr. R., Kleinman J.E., Herman M.M., Li R., et al. Alpha 2 isoform of the Na,K-adenosine triphosphatase is reduced in temporal cortex of bipolar individuals. Biol Psychiatry 44 (1998) 892-897
33. Sich B., Kirch U., Tepel M., Zidek W., and Schoner W. Pulse pressure correlates in humans with a proscillaridin A immunoreactive compound. Hypertension 27 (1996) 1073-1078
34. Tian J., Cai T., Yuan Z., Wang H., Liu L., Haas M., et al. Binding of Src to Na+/K+-ATPase forms a functional signaling complex. Mol Biol Cell 17 (2006) 317-326
35. Traub N., and Lichtstein D. The mood cycle hypothesis: possible involvement of steroid hormones in mood regulation by means of Na+, K+-ATPase inhibition. J Basic Clin Physiol Pharmacol 11 (2000) 375-394
36. Vaillend C., Mason S.E., Cuttle M.F., and Alger B.E. Mechanisms of neuronal hyperexcitability caused by partial inhibition of Na+-K+-ATPases in the rat CA1 hippocampal region. J Neurophysiol 88 (2002) 2963-2978
37. Valjent E., Corvol J.C., Pages C., Besson M.J., Maldonado R., and Caboche J. Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. J Neurosci 20 (2000) 8701-8709
38. Valjent E., Pages C., Rogard M., Besson M.J., Maldonado R., and Caboche J. Delta 9-tetrahydrocannabinol-induced MAPK/ERK and Elk-1 activation in vivo depends on dopaminergic transmission. Eur J Neurosci 14 (2001) 342-352
39. Vatta M., Pena C., Fernandez B.E., and Rodriguez de Lores Arnaiz G. Endobain E, a brain Na+, K+-ATPase inhibitor, decreases norepinephrine uptake in rat hypothalamus. Life Sci 76 (2004) 359-365
40. Xie Z., and Cai T. Na+-K+-ATPase-mediated signal transduction: from protein interaction to cellular function. Mol Interv 3 (2003) 157-168
41. Yuan Z., Cai T., Tian J., Ivanov A.V., Giovannucci D.R., and Xie Z. Na/K-ATPase tethers phospholipase C and IP3 receptor into a calcium-regulatory complex. Mol Biol Cell 16 (2005) 4034-4045